Lower urinary tract symptoms in depression: a review

DJ Anderson, A Aucoin, CR Toups… - Health psychology …, 2023 - pmc.ncbi.nlm.nih.gov
Lower Urinary Tract Symptoms (LUTS) are frequently present in the general population as
patients age with approximately a third of individuals experiencing LUTS during their …

Molecular targets of cannabidiol in experimental models of neurological disease

S Silvestro, G Schepici, P Bramanti, E Mazzon - Molecules, 2020 - mdpi.com
Cannabidiol (CBD) is a non-psychoactive phytocannabinoid known for its beneficial effects
including antioxidant and anti-inflammatory properties. Moreover, CBD is a compound with …

[HTML][HTML] Cannabis sativa CBD extract shows promising antibacterial activity against Salmonella typhimurium and S. Newington

L Gildea, JA Ayariga, OS Ajayi, J Xu, R Villafane… - Molecules, 2022 - mdpi.com
Products derived from Cannabis sativa L. have gained increased interest and popularity. As
these products become common amongst the public, the health and potential therapeutic …

The problem of malnutrition associated with major depressive disorder from a sex-gender perspective

C García-Montero, MA Ortega, MA Alvarez-Mon… - Nutrients, 2022 - mdpi.com
Major depressive disorder (MDD) is an incapacitating condition characterized by loss of
interest, anhedonia and low mood, which affects almost 4% of people worldwide. With rising …

The microbiome and gut endocannabinoid system in the regulation of stress responses and metabolism

RK Srivastava, B Lutz, I Ruiz de Azua - Frontiers in Cellular …, 2022 - frontiersin.org
The endocannabinoid system, with its receptors and ligands, is present in the gut epithelium
and enteroendocrine cells, and is able to modulate brain functions, both indirectly through …

Opportunities, challenges and pitfalls of using cannabidiol as an adjuvant drug in COVID-19

B Malinowska, M Baranowska-Kuczko… - International journal of …, 2021 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection may lead to
coronavirus disease 2019 (COVID-19) which, in turn, may be associated with multiple organ …

Cannabidiol and it fluorinate analog PECS-101 reduces hyperalgesia and allodynia in trigeminal neuralgia via TRPV1 receptors

DM Escobar-Espinal, AN Vivanco-Estela… - Progress in Neuro …, 2024 - Elsevier
Trigeminal neuralgia (TN) is an intense and debilitating orofacial pain. The gold standard
treatment for TN is carbamazepine. This antiepileptic drug provides pain relief with limited …

An update on pharmacotherapy for trigeminal neuralgia

JV Pergolizzi Jr, JA LeQuang… - Expert Review of …, 2024 - Taylor & Francis
Introduction Trigeminal neuralgia is a rare condition that can be effectively treated by
carbamazepine or oxcarbazepine but these older drugs are associated with dose …

[HTML][HTML] Opioid and cannabinoid systems in pain: emerging molecular mechanisms and use in clinical practice, health, and fitness

C Secondulfo, F Mazzeo, GMG Pastorino… - International Journal of …, 2024 - mdpi.com
Pain is an unpleasant sensory and emotional experience. Adequate pain control is often
challenging, particularly in patients with chronic pain. Despite advances in pain …

Selling cannabidiol products in Canada: a framing analysis of advertising claims by online retailers

MA Zenone, J Snyder, V Crooks - BMC public health, 2021 - Springer
Abstract Background In Canada, the legalization of cannabis has enabled cannabidiol
(CBD) to become a popular commercial product, increasingly used for medical or …